<qa>  What is the purpose of this trial?The purpose of this trial is primarily to investigate the safety profile of HuMax-CD20 in patients with active RA. Furthermore, the trial is designed to identify the dose levels to be used in future trials based on evaluations of safety, pharmacokinetics and ACR and DAS responses. 